Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: A prospective randomized study

Journal of Hepatology

Volumn 24, Issue 1, 1996, Pages 88-94

  Ikeda, Takaaki ^a   Tozuka, Shinichi ^a   Noguchi, Osamu ^b   Kobayashi, Fumie ^a   Sakamoto, Shigemi ^a   Marumo, Fumiaki ^b   Sato, Chifumi ^b  

^a YOKOSUKA KYOSAI HOSPITAL   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Colchicine; Primary biliary cirrhosis; Prospective study; Ursodeoxycholic acid

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; COLCHICINE; ENDOGENOUS COMPOUND; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN M; URSODEOXYCHOLIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0030046999     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80191-7     Document Type: Article

References (32)

1. Heathcote J, Ross A, Sherlock S. A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology 1976; 70: 656-60.
2. Crowe J, Christensen E, Smith M, Cochrane M, Ranek L, Watkinson G, Doniach D, Popper H, Tygstrup N, Williams R. Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. Gastroenterology 1980; 78: 1005-10.
3. Mitchison HC, Bassendine MF, Malcolm AJ, Watson AJ, Record CO, James OFW. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss. Hepatology 1989; 10: 420-9.
4. Hoofnagle JH, Davis GL, Schafer DF, Peters M, Avigan MI, Pappas SC, Hanson RG, Minuk GY, Dusheiko GM, Campbell G, MacSween RNM, Jones EA. Randomized trial of chlorambucil for primary biliary cirrhosis. Gastroenterology 1986; 91: 1327-34.
5. Minuk GY, Bohme CE, Burgess E, Hershfield NB, Kelly JK, Shaffer EA, Sutherland LR, Van Rosendaal G. Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Gastroenterology 1988; 95: 1356-63.
6. Wiesner RH, Ludwig J, Lindor KD, Jorgensen RA, Baldus WP, Homburger HA, Dickson ER. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med 1990; 322: 1419-24.
7. James OFW. D-penicillamine for primary biliary cirrhosis. Gut 1985; 26: 109-13.
8. Poupon R, Chretien Y, Poupon RE, Ballet, F, Calmus Y, Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987; i: 834-6.
9. Leuschner U, Fischer H, Kurtz W, Guldutuna S, Hubner K, Hellstern A, Gatzen M, Leuschner M. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled doubleblind trial. Gastroenterology 1989; 97: 1268-74.
10. Poupon RE, Balkau B, Eschwege E, Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991; 324: 1548-54.
11. Hadziyannis SJ, Hadziyannis ES, Makris A. A randomized controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC) (abstr.). Hepatology 1989; 10: 580.
12. Koldinger RE. Treatment of primary biliary cirrhosis with colchicine (abstr). Gastroenterology 1980; 78: 1309.
13. Kaplan MM, Alling DW, Zimmerman HJ, Wolfe HJ, Sepersky RA, Hirsch GS, Elta GH, Glick KA, Eagen KA. A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med 1986; 315: 1448-54.
14. Warnes TW, Smith A, Lee FI, Haboubi NY, Johnson PJ, Hunt L. A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report. J Hepatol 1987; 5: 1-7.
15. Bodenheimer H Jr, Schaffner F, Pezzulo J. Evaluation of colchicine therapy in primary biliary cirrhosis, Gastroenterology 1988; 95: 124-9.
16. Scheuer PJ. Primary biliary cirrhosis. Proc R Soc Med 1967; 60: 1257-60.
17. Koga T, Morikawa Y. Ultrasonographic determination of the splenic size and its clinical usefulness in various liver diseases. Radiology 1975; 115: 157-61.
18. Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, Minuk GY, Pappas SC, Scully LJ, Steinbrecher UP, Sutherland LR, Williams CN, Witt-Sullivan H, Worobetz LJ, Milner RA, Wanless IR. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994; 19: 1149-56.
19. Battezzati PM, Podda M, Bianchi FB, Naccarato R, Orlandd F, Surrenti C, Pagliaro L, Manenti F. Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. J Hepatol 1993; 17: 332-8.
20. Shapiro JM, Smith H, Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 1979; 20: 137-40.
21. Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983; 308: 1-7.
22. Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, Doniach D, Ranek L, Tygstrup N, Williams R. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis: final results of an international trial. Gastroenterology 1985; 89: 1084-91.
23. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989; 10: 1-7.
24. Lindor CD, Dickson ER, Baldus WP, Fisher LD, Langworthy A. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106: 1284-90.
25. Woodbury DM. Analgesic-antipyretics, anti-inflammatory agents, and inhibitors of uric acid synthesis. In: Goodman LS, Gilman A, eds. The Pharmacologic Basis of Therapeutics. New York: McMillan, 1970; 339-62.
26. Malawista SE. The action of colchicine in acute gouty arthritis. Arth Rheum 1975; 18: 835-46.
27. Rajan KT. Lysosomes and gout. Nature 1966; 210: 959-60.
28. Harwood R, Grant ME, Jackson DSS. The influence of a,abipyridyl, colchicine and antimycin A on the secretory process in embryonic-chick tendon and cartilage cells. Biochem J 1976; 156: 81-90.
29. Rojkind M, Uribe M, Kershenobick D. Colchicine and the treatment of liver cirrhosis. Lancet 1973; i: 38-9.
30. Kershenobich D, Uribe M, Suarez GI, Mata JM, Perez-Tamayo R, Rojkind M. Treatment of cirrhosis with colchicine: a double-blind randomized trial. Gastroenterology 1979; 77: 532-6.
31. Poupon RE, Poupon R, Balkau B, The UDCA-PBC Study Group. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994; 330: 1342-7.
32. Kapelman B, Schaffner F. The natural history of primary biliary cirrhosis. Semin Liver Dis 1981; 1: 273-81.